Zycov-d
-
{
- All
- News
- Videos
- Web Stories
-
Zydus Cadila Begins Supply Of Covid Vaccine ZyCoV-D To Government
- Wednesday February 2, 2022
- India News | Asian News International
Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art.
-
www.ndtv.com
-
Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially
- Thursday December 2, 2021
- India News | Press Trust of India
Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.
-
www.ndtv.com
-
India To Buy 1 Crore Zydus Cadila 'Needle-Free' Covid Shots At Rs 265 Each
- Monday November 8, 2021
- India News | Edited by Akhil Kumar
The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20.
-
www.ndtv.com
-
60 Lakh Doses Of Zydus Cadila's Vaccine Ready After Production In October: Report
- Wednesday October 13, 2021
- India News | Asian News International
As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.
-
www.ndtv.com
-
Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre
- Thursday September 30, 2021
- India News | Press Trust of India
The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.
-
www.ndtv.com
-
This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'
- Friday September 24, 2021
- India News | Reuters
Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.
-
www.ndtv.com
-
Cadila Healthcare Surges On Receiving Emergence Use Approval For COVID Vaccine
- Tuesday August 24, 2021
- Edited by: Abhishek Vasudev
ZyCoV-D is a needle-free vaccine administered using The PharmaJet a needle free applicator, which ensures painless intradermal vaccine delivery.
-
www.ndtvprofit.com
-
Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week
- Saturday August 21, 2021
- India News | Asian News International
There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.
-
www.ndtv.com
-
"3 Doses, 66 Per Cent Efficacy": 5 Things To Know About Zydus Cadila's Covid Vaccine For Children
- Friday August 20, 2021
- India News | Edited by Harish Pullanoor
Zydus Cadila's Covid vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organisation (CDSCO).
-
www.ndtv.com
-
1st Covid Vaccine For Children Above 12 Approved In India
- Saturday August 21, 2021
- India News | Reuters
India's drug regulator on Friday approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorised for use in the country.
-
www.ndtv.com
-
India's Zydus Cadila Seeks Nod For Its Covid Vaccine ZyCoV-D
- Thursday July 1, 2021
- India News | Reuters
Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine and that it plans to manufacture up to 120 million doses of the shot annually.
-
www.ndtv.com
-
Zydus Cadila May Seek Emergency Use Approval For Vaccine Next Week: Report
- Friday June 18, 2021
- India News | Press Trust of India
Indian pharmaceutical major Zydus Cadila is likely to apply to the central drugs regulator seeking emergency use authorisation for its COVID-19 vaccine ZyCoV-D next week, official sources said on Friday.
-
www.ndtv.com
-
Zydus Cadila Begins Supply Of Covid Vaccine ZyCoV-D To Government
- Wednesday February 2, 2022
- India News | Asian News International
Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art.
-
www.ndtv.com
-
Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially
- Thursday December 2, 2021
- India News | Press Trust of India
Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.
-
www.ndtv.com
-
India To Buy 1 Crore Zydus Cadila 'Needle-Free' Covid Shots At Rs 265 Each
- Monday November 8, 2021
- India News | Edited by Akhil Kumar
The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20.
-
www.ndtv.com
-
60 Lakh Doses Of Zydus Cadila's Vaccine Ready After Production In October: Report
- Wednesday October 13, 2021
- India News | Asian News International
As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.
-
www.ndtv.com
-
Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre
- Thursday September 30, 2021
- India News | Press Trust of India
The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.
-
www.ndtv.com
-
This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'
- Friday September 24, 2021
- India News | Reuters
Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.
-
www.ndtv.com
-
Cadila Healthcare Surges On Receiving Emergence Use Approval For COVID Vaccine
- Tuesday August 24, 2021
- Edited by: Abhishek Vasudev
ZyCoV-D is a needle-free vaccine administered using The PharmaJet a needle free applicator, which ensures painless intradermal vaccine delivery.
-
www.ndtvprofit.com
-
Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week
- Saturday August 21, 2021
- India News | Asian News International
There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.
-
www.ndtv.com
-
"3 Doses, 66 Per Cent Efficacy": 5 Things To Know About Zydus Cadila's Covid Vaccine For Children
- Friday August 20, 2021
- India News | Edited by Harish Pullanoor
Zydus Cadila's Covid vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organisation (CDSCO).
-
www.ndtv.com
-
1st Covid Vaccine For Children Above 12 Approved In India
- Saturday August 21, 2021
- India News | Reuters
India's drug regulator on Friday approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorised for use in the country.
-
www.ndtv.com
-
India's Zydus Cadila Seeks Nod For Its Covid Vaccine ZyCoV-D
- Thursday July 1, 2021
- India News | Reuters
Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine and that it plans to manufacture up to 120 million doses of the shot annually.
-
www.ndtv.com
-
Zydus Cadila May Seek Emergency Use Approval For Vaccine Next Week: Report
- Friday June 18, 2021
- India News | Press Trust of India
Indian pharmaceutical major Zydus Cadila is likely to apply to the central drugs regulator seeking emergency use authorisation for its COVID-19 vaccine ZyCoV-D next week, official sources said on Friday.
-
www.ndtv.com